Drreddys Laboratories | RDY - Ação





Ação Alterar Data
ANI Pharmaceuticals USD 143.47M 401K 2026-03
Aurora Cannabis CAD 230.56M 8.6M 2025-12
Bayer EUR 12.34B 3M 2025-12
Canopy Growth CAD 105.56M 3.18M 2025-12
Cipla INR 61.6B 5.18B 2025-09
Corcept Therapeutics USD 12.89M 22K 2026-03
Drreddys Laboratories INR 79.01B 3.41B 2025-12
GlaxoSmithKline GBP 6.16B 233M 2026-03
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Lonza CHF 1.68B 163M 2025-12
Novartis USD 6.29B 17M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Phibro Animal Health USD 539.7M 22.35M 2026-03
Prestige Brands USD 159.13M 4.46M 2026-03
Richter Gedeon HUF 205.75B 9.76B 2024-06
Sun Pharmaceuticals INR 102.43B 3.08B 2025-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12